Technical Analysis for GKOS - Glaukos Corporation

Grade Last Price % Change Price Change
grade B 62.68 0.46% 0.29
GKOS closed up 0.46 percent on Friday, January 18, 2019, on 58 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical GKOS trend table...

Date Alert Name Type % Chg
Jan 18 NR7 Range Contraction 0.00%
Jan 18 Inside Day Range Contraction 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Upper Bollinger Band Touch Strength 0.00%
Jan 17 MACD Bullish Centerline Cross Bullish 0.46%
Jan 17 Above Upper BB Strength 0.46%
Jan 17 Overbought Stochastic Strength 0.46%
Jan 17 Upper Bollinger Band Touch Strength 0.46%
Jan 16 Shooting Star Candlestick Bearish 3.06%
Jan 16 Lizard Bearish Bearish Day Trade Setup 3.06%

Older signals for GKOS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Glaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company is engaged in the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring one millimeter long and 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a small corneal incision. Glaukos is also engaged in developing a portfolio of micro-scale injectable therapies, including three pipeline products, namely, the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.
Is GKOS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 70.91
52 Week Low 26.75
Average Volume 499,884
200-Day Moving Average 49.0311
50-Day Moving Average 59.3992
20-Day Moving Average 56.3805
10-Day Moving Average 58.788
Average True Range 2.7307
ADX 17.82
+DI 28.3483
-DI 19.0787
Chandelier Exit (Long, 3 ATRs ) 55.9379
Chandelier Exit (Short, 3 ATRs ) 58.7921
Upper Bollinger Band 62.9397
Lower Bollinger Band 49.8213
Percent B (%b) 0.98
BandWidth 23.267619
MACD Line 0.513
MACD Signal Line -0.5346
MACD Histogram 1.0476
Fundamentals Value
Market Cap 2.15 Billion
Num Shares 34.4 Million
EPS -0.04
Price-to-Earnings (P/E) Ratio -1567.00
Price-to-Sales 8.40
Price-to-Book 9.34
PEG Ratio -14.23
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 65.23
Resistance 3 (R3) 65.09 64.10 64.81
Resistance 2 (R2) 64.10 63.45 64.17 64.66
Resistance 1 (R1) 63.39 63.05 62.90 63.53 64.52
Pivot Point 62.40 62.40 62.15 62.47 62.40
Support 1 (S1) 61.69 61.75 61.20 61.83 60.84
Support 2 (S2) 60.70 61.35 60.77 60.70
Support 3 (S3) 59.99 60.70 60.56
Support 4 (S4) 60.13